Filing Details

Accession Number:
0001179110-13-009876
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-06 17:19:11
Reporting Period:
2013-06-06
Filing Date:
2013-06-06
Accepted Time:
2013-06-06 17:19:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1157601 Synta Pharmaceuticals Corp SNTA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325719 R Safi Bahcall C/O Synta Pharmaceuticals Corp.
45 Hartwell Avenue
Lexington MA 02421
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-06-06 10,000 $4.04 1,993,135 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 15,000 Indirect By Safi R. Bahcall Irrevocable Trust
Common Stock 65,000 Indirect By Neta Bahcall 2012 Irrevocable Trust
Common Stock 400,000 Indirect By Princeton GRAT
Footnotes
  1. The shares were purchased in multiple transactions at prices ranging from $4.03 to $4.04 per share. The price reported above is the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth above.
  2. Reflects the transfer of 400,000 shares on May 30, 2013 from Dr. Bahcall to a grantor retained annuity trust.
  3. The Reporting Person disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.